FDA floats possible approach to repurpose approved drugs under new uses
The FDA is looking to get thrifty with its approved drugs. The framework would leverage existing safety data on approved drugs to provide new options to patients with unmet medical needs, the FDA explained.
The framework would leverage existing safety data on approved drugs to provide new options to patients with unmet medical needs, the FDA explained.
Source: FiercePharma